Search Results - "Cuiffo, Benjamin G."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Mesenchymal stem cells in tumor development: Emerging roles and concepts by Cuiffo, Benjamin G., Karnoub, Antoine E.

    Published in Cell adhesion & migration (01-05-2012)
    “…Mesenchymal stem cells (MSCs) are multipotent progenitor cells that participate in the structural and functional maintenance of connective tissues under normal…”
    Get full text
    Journal Article
  3. 3

    GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling by Pulsipher, Abigail, Savage, Justin R, Kennedy, Thomas P, Gupta, Kavita, Cuiffo, Benjamin G, Sonis, Stephen T, Lee, Won Yong

    Published in PloS one (26-03-2021)
    “…Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell‐Like Phenotypic Traits in Triple‐Negative Breast Cancers by Tu, Zhenbo, Schmöllerl, Johannes, Cuiffo, Benjamin G., Karnoub, Antoine E.

    Published in Stem cells (Dayton, Ohio) (01-10-2019)
    “…The fibrotic tumor microenvironment is a critical player in the pathogenesis of triple‐negative breast cancers (TNBCs), with the presence of fibroblastic…”
    Get full text
    Journal Article
  6. 6

    Lysosomal proteases are involved in generation of N-terminal huntingtin fragments by Kim, Yun J., Sapp, Ellen, Cuiffo, Benjamin G., Sobin, Lindsay, Yoder, Jennifer, Kegel, Kimberly B., Qin, Zheng-Hong, Detloff, Peter, Aronin, Neil, DiFiglia, Marian

    Published in Neurobiology of disease (01-05-2006)
    “…N-terminal mutant huntingtin (N-mhtt) fragments form inclusions and cause cell death in vitro. Mutant htt expression stimulates autophagy and increases levels…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Silencing FOXP2 in breast cancer cells promotes cancer stem cell traits and metastasis by Cuiffo, Benjamin G., Karnoub, Antoine E.

    Published in Molecular & cellular oncology (03-05-2016)
    “…In a recent article in Cell Stem Cell, we showed that mesenchymal stem cells (MSCs), progenitor cells that populate the breast tumor stroma, induce…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abstract 585: Colitis in tumor-bearing mice undergoing checkpoint inhibitor therapy by Parello, Caitlin S., Cuiffo, Benjamin G., Reardon, Kasey, Fusco, Alexandria, Van Dam, Brett, Lyng, Gregory D., Sonis, Stephen T.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Checkpoint inhibitor (CPI) therapy represents an exciting new treatment option for patients with advanced malignancies. However, several adverse…”
    Get full text
    Journal Article
  11. 11

    Abstract 1146: Early PD-1 inhibition abrogates PBMC engraftment in a triple-humanized (tumor/PBMC/MSC) bioluminescent orthotopic model of pancreatic cancer by Cuiffo, Benjamin G., Parello, Caitlin S., Ritchie, Chelsea, Kury, Alexandra, Anderson, Scott, Lyng, Gregory D., Sonis, Stephen T.

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Accuracy of context is critical in efforts to improve the translational potential of preclinical oncology models. Pancreatic cancer has high mortality…”
    Get full text
    Journal Article
  12. 12

    Abstract 5113: INTASYL self-delivering RNAi therapeutic dual targeting PD-1 and CTLA-4 provides synergistic antitumor efficacy in the treatment of murine colon cancer in vivo by Cuiffo, Benjamin G., Boone, Andrew, Yan, Dingxue, Maxwell, Melissa, Rivest, Brianna, Cardia, James, Fricker, Simon P.

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Combination immune checkpoint inhibition (ICI) with antibodies targeting PD-1 and CTLA-4 provides superior outcomes compared to either monotherapy…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Palmitoylation of Oncogenic NRAS Is Essential for Leukemogenesis by Cuiffo, Benjamin G., Ren, Ruibao

    Published in Blood (16-11-2007)
    “…Activating mutations of NRAS are found in 20%–40% of acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and myelodysplastic syndrome (MDS)…”
    Get full text
    Journal Article
  19. 19